09:45 AM EST - Avivagen Inc. : Announced preliminary results of a trial of OxC-beta as a feed additive in broiler poultry conducted by the Institute of Agro-food Research and Technology of Catalonia, Spain. The preliminary trial results suggest that the higher dose of OxC-beta that was tested offers a level of protection against the trial challenges. The characteristics of this broiler poultry trial, including the circumstance of a record heat-wave during the trial, are summarized herein. Avivagen Inc.
shares V.VIV are trading unchanged at $0.06.
